🇺🇸 FDA
Patent

US 9056924

Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571

granted A61PA61P35/00

Quick answer

US patent 9056924 (Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571) held by The Regents of the University of California expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61P, A61P35/00